Silverwood Partners
  • About Us
    • Overview
    • Why Silverwood?
    • Careers
    • Our Location
    • Connect With Us
  • Insights & Analysis
    • Newsletters
    • Intelligence Briefs
    • Events
    • Connect With Us
  • Team
    • All Team
    • Technology
    • Consumer
    • Healthcare
  • Industry Experience
    • Technology
    • Consumer
    • Healthcare
    • Connect With Us
  • Services
    • Mergers & Acquisitions
    • Private Placements
    • Connect With Us
  • Transactions
    • All Transactions
    • Technology
    • Consumer
    • Healthcare
    • Connect With Us
Select Page
Healthcare Private Placement and M&A Transactions Review Week Ending January 15 2023

Healthcare Private Placement and M&A Transactions Review Week Ending January 15 2023

by Jonathan Hodson-Walker | Jan 18, 2023 | Healthcare

Strategy | Financing Highlight  Private Placement / Financing Transactions Carbon Health: The company raised $100 million of Series D-2 venture funding in a deal led by CVS Health Ventures on January 9, 2023, putting the company’s pre-money valuation at $1.3...
Healthcare Private Placement and M&A Transactions Review Week Ending January 8 2023

Healthcare Private Placement and M&A Transactions Review Week Ending January 8 2023

by Jonathan Hodson-Walker | Jan 10, 2023 | Healthcare

Strategy | Financing Highlight  Private Placement / Financing Transactions Synthekine: The company raised $100 million of Series C venture funding in a deal led by The Column Group on January 6, 2023. The company is a developer of engineered cytokine therapeutics...
Healthcare Private Placement and M&A Transactions Review Week Ending January 1 2023

Healthcare Private Placement and M&A Transactions Review Week Ending January 1 2023

by Jonathan Hodson-Walker | Jan 5, 2023 | Healthcare

Strategy | Financing Highlight  Private Placement / Financing Transactions NextPoint: The company raised $80 million of venture funding from undisclosed investors on December 19, 2022. The company is a developer of medications intended to expand the benefit of...
Healthcare Private Placement and M&A Transactions Review Week Ending December 18 2022

Healthcare Private Placement and M&A Transactions Review Week Ending December 18 2022

by Jonathan Hodson-Walker | Dec 22, 2022 | Healthcare

Strategy | Financing Highlight – Click on the image below to read our CES Analysis Private Placement / Financing TransactionsHistoSonics: The company raised $100 million of venture funding in a deal led by Johnson & Johnson Innovation – JJDC on...
Healthcare Private Placement and M&A Transactions Review Week Ending December 11 2022

Healthcare Private Placement and M&A Transactions Review Week Ending December 11 2022

by Jonathan Hodson-Walker | Dec 13, 2022 | Healthcare

Strategy | Financing Highlight Private Placement / Financing Transactions Entactbio: The company raised $81 million in Series A venture funding in a deal led by Qiming Venture Partners and venBio on December 6, 2022, putting the company’s pre-money valuation at...
Healthcare Private Placement and M&A Transactions Review Week Ending December 4 2022

Healthcare Private Placement and M&A Transactions Review Week Ending December 4 2022

by Jonathan Hodson-Walker | Dec 8, 2022 | Healthcare

Strategy | Financing Highlight Private Placement / Financing Transactions Strand Therapeutics: The company raised $97 million in Series A venture funding in a deal led by FPV Ventures on November 28, 2022. Eli Lilly, BeiGene, Potentum Partners, Starlight Ventures,...
« Older Entries
Next Entries »

Search

Recent Posts

  • Technology Private Placement and M&A Transactions Review Week Ending September 7, 2025
  • Consumer Private Placement and M&A Transactions Review Week Ending September 7, 2025
  • Healthcare Private Placement and M&A Transactions Review Week Ending September 7, 2025
  • Technology Private Placement and M&A Transactions Review Week Ending August 31, 2025
  • Consumer Private Placement and M&A Transactions Review Week Ending August 31, 2025

Categories

Archives